SEC EDGAR · Insider purchase
PHIO: Plott Ronald Todd reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow PHIO- Became public
- Nov 10, 2026, 11:18 AM EST
- Event / period date
- Nov 9, 2026
- Collected
- Nov 10, 2026, 11:27 AM EST
Why this is connected
This filing identifies Phio Pharmaceuticals Corp. as the issuer of the security. The company's SEC identifier connects it to PHIO.
Reported transactions
Plott Ronald Todd (Director)
18,300 shares · Common Stock, $.0001 par value
Nov 9, 2026 · $0.83 per share
Value calculated from the reported shares and prices: $15,189.00.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-09</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0001533040</issuerCik>
<issuerName>Phio Pharmaceuticals Corp.</issuerName>
<issuerTradingSymbol>PHIO</issuerTradingSymbol>
<issuerForeignTradingSymbol></issuerForeignTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001768337</rptOwnerCik>
<rptOwnerName>Plott Ronald Todd</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>C/O PHIO PHARMACEUTICALS CORP</rptOwnerStreet1>
<rptOwnerStreet2>411 SWEDELAND RD., STE 23-1080</rptOwnerStreet2>
<rptOwnerCity>KING OF PRUSSIA</rptOwnerCity>
<rptOwnerState>PA</rptOwnerState>
<rptOwnerZipCode>19406</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>1</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>0</isTenPercentOwner>
<isOther>0</isOther>
<officerTitle></officerTitle>
<otherText></otherText>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock, $.0001 par value</value>
</securityTitle>
<transactionDate>
<value>2026-11-09</value>
</transactionDate>
<deemedExecutionDate></deemedExecutionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness></transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>18300</value>
</transactionShares>
<transactionPricePerShare>
<value>0.83</value>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>60300</value>
<footnoteId id="F1"/>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>D</value>
</directOrIndirectOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">Includes shares of common stock underlying unvested restricted stock units.</footnote>
</footnotes>
<ownerSignature>
<signatureName>/s/ Lisa C. Carson, Attorney-in-fact</signatureName>
<signatureDate>2026-11-10</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.